GPCR Structure Therapeutics Inc.
Healthcare$39.04+0.00%OpenMarket Cap: $2.25B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
1.96
P/S
0.00
EV/EBITDA
-10.22
DCF Value
$13.18
FCF Yield
-7.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-15.1%
ROA
-11.3%
ROIC
-14.4%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-89.6M | $-76.2M | $— | — |
| Q4 null | $0.00 | NaN% | $24.0M | $33.0M | $— | — |
| FY null | $0.00 | -Infinity% | $-287.6M | $-141.2M | $— | — |
| Q3 null | $0.00 | NaN% | $-73.8M | $-65.7M | $— | — |
| Q2 null | $0.00 | NaN% | $-70.5M | $-61.7M | $— | — |
| Q1 null | $0.00 | NaN% | $-56.3M | $-46.8M | $— | — |
| Q4 null | $0.00 | NaN% | $-47.1M | $-36.5M | $— | — |
| FY null | $0.00 | NaN% | $-158.2M | $-122.5M | $— | — |
| Q3 null | $0.00 | NaN% | $-45.8M | $-34.0M | $— | — |
| Q2 null | $0.00 | NaN% | $-33.3M | $-26.0M | $— | — |
| Q1 null | $0.00 | NaN% | $-32.0M | $-26.0M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-31.0M | $-24.5M | $-0.54 | — |